Eisai

Top News

• Eisai and Osaka Prefecture Enter into Collaboration to Promote Awareness of Dementia and Mild Cognitive ...

  JCN Newswire 2026-09-15, 12:00

  TOKYO, September 15, 2026 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito,...

• Pfizer and Eisai Commence Co-promotion of "NURTEC(R)" for the Acute Treatment and Prophylaxis (Preventive Treatment) ...

  JCN Newswire 2026-07-27, 12:00

  TOKYO, July 27, 2026 - (JCN Newswire) - Pfizer Japan Inc. (Headquarters: Tokyo, President and Representative...

• FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug

  The Economic Times 2026-07-14, 04:54

  The US FDA approved an at-home starting dose for Eisai and Biogen's...

• Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference® (AAIC®) 2026

  PR Newswire 2026-07-13, 09:15

  Measuring the plasma eMTBR-tau243 biomarker may serve as a practical, less invasive method of capturing...